$0.03
40.09% yesterday
Nasdaq, Aug 11, 09:49 pm CET
ISIN
CA21872J3073
Symbol
CLABF

Core One Labs Stock price

$0.02
+0.00 0.00% 1M
-0.06 72.22% 6M
-0.07 75.33% YTD
-0.08 78.53% 1Y
-0.22 90.77% 3Y
-4.24 99.48% 5Y
-7.56 99.71% 10Y
-15.05 99.85% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.00 0.00%
ISIN
CA21872J3073
Symbol
CLABF
Industry

Key metrics

Basic
Market capitalization
$5.0m
Enterprise Value
$5.0m
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | -
P/S
7.3 | -
EV/Sales
7.4 | -
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
82.8%
Return on Equity
-297.5%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
-
FCF per Share
-
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Core One Labs a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Financial data from Core One Labs

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '23
+/-
%
0.68 0.68
45% 45%
100%
- Direct Costs 0.01 0.01
-
1%
0.19 0.19
-
28%
- Selling and Administrative Expenses 9.06 9.06
47% 47%
1,332%
- Research and Development Expense 0.12 0.12
140% 140%
18%
-7.57 -7.57
57% 57%
-1,113%
- Depreciation and Amortization 0.06 0.06
50% 50%
9%
EBIT (Operating Income) EBIT -7.63 -7.63
58% 58%
-1,123%
Net Profit -16 -16
41% 41%
-2,397%

In millions USD.

Don't miss a Thing! We will send you all news about Core One Labs directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. Its focus is to bring psychedelic medicines to market through novel delivery systems and psychotherapy. The firm offers isogenics, cultivation, extraction and distillation, consulting, cannastrips, and quality and control. The company was founded on September 14, 2010 and is headquartered in Vancouver, Canada.

Head office Canada
CEO Joel Shacker
Founded 2010
Website core1labs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today